Order Article Reprints

Pinato DJ, Kaneko T, Saeed A, Pressiani T, Kaseb A, Wang Y, Szafron D, Jun T, Dharmapuri S, Naqash AR, et al. Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade. Cancers. 2020; 12(7):1862. https://doi.org/10.3390/cancers12071862

Pinato, David J., Takahiro Kaneko, Anwaar Saeed, Tiziana Pressiani, Ahmed Kaseb, Yinghong Wang, David Szafron, Tomi Jun, Sirish Dharmapuri, Abdul Rafeh Naqash, and et al. 2020. "Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade" Cancers 12, no. 7: 1862. https://doi.org/10.3390/cancers12071862

Pinato, D. J., Kaneko, T., Saeed, A., Pressiani, T., Kaseb, A., Wang, Y., Szafron, D., Jun, T., Dharmapuri, S., Naqash, A. R., Muzaffar, M., Navaid, M., Lee, C.-J., Bulumulle, A., Yu, B., Paul, S., Nimkar, N., Bettinger, D., Hildebrand, H., ... Huang, Y.-H. (2020). Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade. Cancers, 12(7), 1862. https://doi.org/10.3390/cancers12071862